| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2024/02/09 | 09 : 22 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 2023/10/20 | 05 : 48 | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section 12(g)] | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 2023/10/12 | 13 : 15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 2023/10/11 | 23 : 17 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 2023/10/11 | 23 : 12 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 2023/10/11 | 23 : 05 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 2023/10/11 | 23 : 02 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 2023/10/11 | 22 : 27 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 2023/10/11 | 22 : 27 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 2023/10/11 | 22 : 24 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 2023/10/11 | 22 : 22 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 2023/10/11 | 22 : 22 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 2023/10/11 | 22 : 22 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 2023/10/11 | 22 : 22 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 2023/10/11 | 22 : 21 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 2023/10/11 | 22 : 20 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 2023/10/11 | 22 : 19 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 2023/10/11 | 22 : 19 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 2023/10/11 | 21 : 56 | Edgar (US Regulatory) | Form SC 14D9/A - Solicitation, recommendation statements: [Amend] | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 2023/10/11 | 21 : 31 | Edgar (US Regulatory) | Form SC TO-T/A - Tender offer statement by Third Party: [Amend] | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 2023/10/11 | 21 : 17 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 2023/10/11 | 21 : 00 | PR Newswire (US) | HARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA PHARMACEUTICALS AND EXPANDS PIPELINE | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 2023/10/05 | 06 : 29 | Edgar (US Regulatory) | Form SC 14D9/A - Solicitation, recommendation statements: [Amend] | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 2023/10/05 | 05 : 05 | GlobeNewswire Inc. | Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and Instructions | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 2023/09/29 | 22 : 00 | GlobeNewswire Inc. | Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023 | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 2023/09/27 | 21 : 25 | Edgar (US Regulatory) | Form SC 14D9/A - Solicitation, recommendation statements: [Amend] | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 2023/09/27 | 21 : 12 | Edgar (US Regulatory) | Form SC TO-T/A - Tender offer statement by Third Party: [Amend] | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 2023/09/27 | 21 : 00 | PR Newswire (US) | HARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC. | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 2023/09/15 | 21 : 00 | Edgar (US Regulatory) | Form SC 14D9/A - Solicitation, recommendation statements: [Amend] | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |
| 2023/09/15 | 05 : 59 | Edgar (US Regulatory) | Form SC TO-T/A - Tender offer statement by Third Party: [Amend] | NASDAQ:ZYNE | Zynerba Pharmaceuticals Inc |